Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis

Abstract Background The therapeutic status of allogeneic stem cell transplantation (allo-SCT) as a post-remission treatment for patients with high-risk acute myeloid leukemia (AML) was well-accepted. However, the optimal treatment for patients with low/favorable- or intermediate-risk AML who achieve...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Wu Ye, Xia Wu, Ruying Zhao, Xuelian Jin, Hui Li, Ying Qu, Jie Ji, Zhigang Liu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2024-05-01
סדרה:	Stem Cell Research & Therapy
נושאים:	Acute myeloid leukemia Allo-SCT Auto-SCT Chemotherapy Network-comparison
גישה מקוונת:	https://doi.org/10.1186/s13287-024-03766-5
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!